Queensland ban on puberty blockers for gender dysphoria to continue until at least 2031, LNP announces
In Queensland, Australia, the pause on puberty blockers and hormone treatments for new adolescent patients with gender dysphoria in the public health system will continue until at least 2031. This announcement was made by Queensland's health minister, Tim Nicholls, on Friday.

Briefing Summary
AI-generatedIn Queensland, Australia, the pause on puberty blockers and hormone treatments for new adolescent patients with gender dysphoria in the public health system will continue until at least 2031. This announcement was made by Queensland's health minister, Tim Nicholls, on Friday. The decision remains in place despite an independent review led by Prof Ruth Vine, Victoria's former chief psychiatrist. The review concluded that treatment decisions should be based on individual circumstances. The pause affects the availability of these treatments for new adolescent patients within Queensland's public healthcare system. The reason for the extended pause was not explicitly stated in the provided text.
Article analysis
Model · rule-basedKey claims
6 extractedReview by Victoria’s former chief psychiatrist, Prof Ruth Vine, now made public.
Treatment decisions ‘must be informed by each individual’s presentation and circumstances’.
Pause on puberty blockers and hormone treatment in Queensland will continue until at least 2031.
Treatment decisions “must be informed by each individual’s presentation and circumstances”.
Pause on puberty blockers and hormone treatment for new adolescent patients with gender dysphoria in Queensland's public system will continue until at least 2031.
Decision comes despite independent review finding that treatment decisions ‘must be informed by each individual’s presentation and circumstances’